Potassium- and Lithium-Ammonia Intercalation into Excitonic Insulator Candidate Ta(2)NiSe(5).
Names both Lithium and Potassium in its title.
Supplement × Prescription·Evidence index
PubMed indexes 7 records that name Lithium and Potassium together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.
Every statement below is attributed to a named, dated, linked source.
This page lists published research relevant to Lithium and Potassium. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.
Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.
Names both Lithium and Potassium in its title.
“Sodium citrate also presents radiological properties close to soft tissue. Therefore, considering all properties, in the set of the new materials studied in this work, sodium citrate is a promising material for ESR dosimetry.”
Names both Lithium and Potassium in its title.
Names both Lithium and Potassium in its title.
Names both Lithium and Potassium in its title.
“Hypokalemia should be avoided or corrected in patients taking lithium. The role of potassium supplementation in preventing renal and other complications in the presence of normokalemia requires further investigation.”
Names both Lithium and Potassium in its title.
“These results suggest that lithium's toxic, but not behavioral, actions involve an interaction with potassium ion. Furthermore, dietary potassium supplementation might have independent uses as treatment for chronobiological disorders.”
Names both Lithium and Potassium in its title.
“Lithium is effective in achieving rapid biochemical control of hyperthyroidism and may serve as a valuable bridging option for patients in whom antithyroid therapy is contraindicated or not tolerated. However, the potential for early renal concentration and calcium metabolism disturbances warrants vigilant monitoring.”
Names Lithium and Potassium together in an interaction, co-administration, or pharmacokinetic context.
Search-based evidence indexes have real limits, and it is worth being explicit about them:
NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Lithium, Potassium, and several hundred other substances.
The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.